Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-11

Clinical Trial Update: Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel [Phase 4]

View source ↗

Summary

Phase 4, single-center, randomized, double-blind, crossover trial comparing fexofenadine HCl 180 mg, cetirizine 10 mg, and placebo on cognitive performance in n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine HCl 180 mg (fexofenadine)
  • cetirizine 10 mg (cetirizine)

Snippet

Sponsor: Sanofi | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED